Andrew Pipingas

Andrew Pipingas

Auto-generated profile, based on publicly available information

Andrew Pipingas

Swinburne University of Technology

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Neuropsychiatric Disease and Treatment
Verified
Journal Article
Open access
PDF file
FLFlorence Levy
Florence Levy
APAndrew Pipingas
Andrew Pipingas
EHElizabeth V Harris
Elizabeth V Harris
MFMaree Farrow
Maree Farrow
RSRichard B Silberstein
Richard B Silberstein
Continuous performance task in ADHD: Is reaction time variability a key measure? Florence Levy,1 Andrew Pipingas,2 Elizabeth V Harris,2 Maree Farrow,3 Richard B Silberstein2 1School of Psychiatry, University of New South Wales and Head, Child and Family East, Prince of Wales Hospital, Sydney, NSW, Australia; 2Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, Victoria, Australia; 3Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, Tasmania, Australia Objective: To compare the use of the Continuous Performance Task (CPT) reaction time variability (intraindividual variability or standard deviation of reaction time), as a measure of vigilance in attention-deficit hyperactivity disorder (ADHD), and stimulant medication response, utilizing a simple CPT X-task vs an A-X-task. Method: Comparative analyses of two separate X-task vs A-X-task data sets, and subgroup analyses of performance on and off medication were conducted. Results: The CPT X-task reaction time variability had a direct relationship to ADHD clinician severity ratings, unlike the CPT A-X-task. Variability in X-task performance was reduced by medication compared with the children’s unmedicated performance, but this effect did not reach significance. When the coefficient of variation was applied, severity measures and medication response were significant for the X-task, but not for the A-X-task. Conclusion: The CPT-X-task is a useful clinical screening test for ADHD and medication response. In particular, reaction time variability is related to default mode interference. The A-X-task is less useful in this regard. Keywords: ADHD, continuous performance task, reaction time variability, stimulant medication

1 January 2019 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
JNJoanna Nkyekyer
Joanna Nkyekyer
DMDenny Meyer
Denny Meyer
APAndrew Pipingas
Andrew Pipingas
NRNicholas S Reed
Nicholas S Reed
Purpose: Our study assessed the efficacy of the simultaneous use of hearing aids and auditory training for improving cognition and psychosocial function in adults with hearing loss, and the relationships between hearing loss, speech perception and cognition. Participants and methods: A 40-person (aged 50–90 years) pilot study in Melbourne, Australia, was conducted. Participants with hearing impairment completed the Geriatric Depression Scale-Short Form, questions about social activity participation, a wide range of cognitive tasks and a speech perception test at baseline, 3 and 6 months. Participants underwent auditory training for 6 months and used hearing aids for 3 months. Results: Correlations and structural equation modeling suggested that several cognitive domains were associated with speech perception at baseline, but only the Incongruent Stroop cognition measure was associated with hearing loss. Hearing aid use reduced problems with communication, but there were no significant improvements in speech perception, social interaction or cognition. The effect of hearing aids and auditory training for improving depressive symptoms was significant with a moderate to large effect size (Cohen’s d=0.87). Conclusion: The small sample size and a relatively high rate of attrition meant that this study was underpowered. However, baseline results suggested relationships between hearing loss, speech perception and cognition, and the hearing intervention provided evidence of reduced depressive symptoms. A full-scale, randomized hearing loss intervention and a longer neuroimaging study with cognitive outcomes measured in the short term as well as after several years of hearing aid use are needed.

2 May 2023 in Experimental Gerontology
Verified
Journal Article
Open access
KSKaren Savage
Karen Savage
CPClaire Porter
Claire Porter
EBEmily Bunnett
Emily Bunnett
MHMaher Hana
Maher Hana
AKAndrew Keegan
Andrew Keegan
APAndrew Pipingas
Andrew Pipingas

17 April 2019 in Nutrition & Dietetics
Verified
Journal Article
Open access
PDF file
WMWolfgang Marx
Wolfgang Marx
EGElena George
Elena George
Hannah L MayrHannah L Mayr
Hannah L Mayr
CTColleen Thomas
Colleen Thomas
KSKaterina Sarapis
Katerina Sarapis
Catherine ItsiopoulosCatherine Itsiopoulos
Catherine Itsiopoulos
Background: Previous clinical studies have suggested that high polyphenol extra virgin olive oil (EVOO) provides a superior cardioprotective effect compared to low polyphenol olive oil. However, further studies are required to replicate these results in non‐Mediterranean populations.Aim: To investigate the effect of high polyphenol EVOO versus low polyphenol olive oil with known polyphenol composition on markers of cardiovascular disease risk in a healthy non‐Mediterranean cohort.Methods: In a double‐blind randomised cross‐over trial, the present study will examine the effect of high polyphenol EVOO versus low polyphenol olive oil in 50 healthy participants. Each intervention phase will be 3 weeks long with a 2‐week washout period between each phase. Outcomes to be assessed include HDL cholesterol efflux, oxidised LDL, blood lipids, C‐reactive protein, arterial stiffness, blood pressure and cognitive function. Dietary intake, physical activity levels and anthropometry will also be collected.Discussion: Because of the rigorous trial design, novel and clinically relevant outcomes, the use of a well‐characterised EVOO, and, in contrast to the current literature, the non‐Mediterranean study population, the present study will provide a significant contribution to the understanding of the clinical importance of polyphenol intake in the Australian sociocultural context.

16 January 2024 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
LAL. Arnoldy
L. Arnoldy
SGSarah Gauci
Sarah Gauci
ALAnnie-Claude M. Lassemillante
Annie-Claude M. Lassemillante
Joris C VersterJoris C Verster
Joris C Verster
HMHelen Macpherson
Helen Macpherson
DWDavid J. White
David J. White
Healthy dietary patterns such as the Mediterranean diet (MeDi), Dietary Approaches to Stop Hypertension (DASH) and the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) have been evaluated for their potential association with health outcomes. However, the lack of standardisation in scoring methodologies can hinder reproducibility and meaningful cross-study comparisons. Here we provide a reproducible workflow for generating the MeDi, DASH and MIND dietary pattern scores from frequently used dietary assessment tools including the 24-h recall tool and two variations of FFQ. Subjective aspects of the scoring process are highlighted and have led to a recommended reporting checklist. This checklist enables standardised reporting with sufficient detail to enhance the reproducibility and comparability of their outcomes. In addition to these aims, valuable insights in the strengths and limitations of each assessment tool for scoring the MeDi, DASH and MIND diet can be utilised by researchers and clinicians to determine which dietary assessment tool best meets their needs.

23 March 2018 in JMIR Research Protocols
Verified
Journal Article
Open access
JNJoanna Nkyekyer
Joanna Nkyekyer
DMDenny Meyer
Denny Meyer
PBPeter J Blamey
Peter J Blamey
APAndrew Pipingas
Andrew Pipingas
SBSunil Bhar
Sunil Bhar
Sensorineural hearing loss is the most common sensory deficit among older adults. Some of the psychosocial consequences of this condition include difficulty in understanding speech, depression, and social isolation. Studies have shown that older adults with hearing loss show some age-related cognitive decline. Hearing aids have been proven as successful interventions to alleviate sensorineural hearing loss. In addition to hearing aid use, the positive effects of auditory training-formal listening activities designed to optimize speech perception-are now being documented among adults with hearing loss who use hearing aids, especially new hearing aid users. Auditory training has also been shown to produce prolonged cognitive performance improvements. However, there is still little evidence to support the benefits of simultaneous hearing aid use and individualized face-to-face auditory training on cognitive performance in adults with hearing loss. This study will investigate whether using hearing aids for the first time will improve the impact of individualized face-to-face auditory training on cognition, depression, and social interaction for adults with sensorineural hearing loss. The rationale for this study is based on the hypothesis that, in adults with sensorineural hearing loss, using hearing aids for the first time in combination with individualized face-to-face auditory training will be more effective for improving cognition, depressive symptoms, and social interaction rather than auditory training on its own. This is a crossover trial targeting 40 men and women between 50 and 90 years of age with either mild or moderate symmetric sensorineural hearing loss. Consented, willing participants will be recruited from either an independent living accommodation or via a community database to undergo a 6-month intensive face-to-face auditory training program (active control). Participants will be assigned in random order to receive hearing aid (intervention) for either the first 3 or last 3 months of the 6-month auditory training program. Each participant will be tested at baseline, 3, and 6 months using a neuropsychological battery of computer-based cognitive assessments, together with a depression symptom instrument and a social interaction measure. The primary outcome will be cognitive performance with regard to spatial working memory. Secondary outcome measures include other cognition performance measures, depressive symptoms, social interaction, and hearing satisfaction. Data analysis is currently under way and the first results are expected to be submitted for publication in June 2018. Results from the study will inform strategies for aural rehabilitation, hearing aid delivery, and future hearing loss intervention trials. ClinicalTrials.gov NCT03112850; https://clinicaltrials.gov/ct2/show/NCT03112850 (Archived by WebCite at http://www.webcitation.org/6xz12fD0B).